Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug ...
Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data expected by early 2025 Completed Phase ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool ... into its Population Health Dashboard and retrospective data displays, ...
Do you work at Palo Alto University? Manage your school's public image and connection with students using U.S. News Student Connect.
Hudson Pacific Properties ( (HPP) ) has released its Q3 earnings. Here is a breakdown of the information Hudson Pacific Properties presented to ...
The Stanford Prison Experiment remains one of psychology’s most controversial studies, exploring how ordinary people might ...
11d
LONDON, GREATER LONDON, UNITED KINGDOM, November 5, 2024 /EINPresswire / -- The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only!
Sophos has installed monitoring software on its customers' systems for years – in the name of security, of course. Jürgen ...
Research from Palo Alto Networks found that the average cost of a ransomware ... Rowe stressed the importance of a thorough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback